David Litvak, MD, MBA, FACS
Chair, Department of Surgery at Cancer Treatment Centers of America®; Chief of Staff
Western Regional Medical Center
- University of Chicago, Pritzker School of Medicine
Internship / Residency
- Surgery - University of California, Davis - East Bay, Oakland
- MBA - Arizona State University, Tempe, AZ
- American Board of Surgery
- Research - University of Texas Medical Branch, Galveston
- Surgical Oncology - John Wayne Cancer Institute, Santa Monica, CA
Practicing Since: 2002
An expert surgical oncologist at our hospital in Arizona, Dr. David Litvak is part of a multidisciplinary care team that provides patient-centered cancer care each day.
Dr. Litvak, the hospital's Chief of Staff, serves as Chair of the Department of Surgery for Cancer Treatment Centers of America® (CTCA). He also performs hyperthermic intraperitoneal chemotherapy (HIPEC), which is a highly concentrated, heated chemotherapy treatment delivered directly to the abdomen during surgery.
Dr. Litvak earned a medical degree from the University of Chicago Pritzker School of Medicine and a bachelor’s degree from the University of California in San Diego.
Following medical school, Dr. Litvak completed a surgical internship and residency at the University of California, Davis-East Bay, where he served as Chief Resident in the Department of Surgery. He also completed a research fellowship at the University of Texas Medical Branch in Galveston and a surgical oncology fellowship at John Wayne Cancer Institute in Santa Monica, California. He also earned a master’s degree in business administration from Arizona State University.
Prior to joining the Western team, Dr. Litvak served for two years as a cancer liaison physician for the American College of Surgeons Committee on Cancer.
Dr. Litvak has presented at 15 national meetings on clinical and basic cancer research. He has also authored 27 articles and four abstracts in various journals, including the Archives of Surgery, the Journal of the American College of Surgeons and the Journal of the National Cancer Institute.